26 Documents disponibles dans cette série
The use of mass media campaigns as a drug prevention intervention is relatively common, but it is not without controversy. Both policymakers and practitioners have debated the effectiveness of such campaigns in reducing drug use among young peop[...]
The European market for hashish is currently one of the world's largest and most profitable. About 647 tons of cannabis herb and 641 tons of hashish were consumed in the European Union in 2013 and the retail market has an overall value estimated[...]
Cannabis is Europe's most commonly used illicit drug, with approximately 20 million adults, or around 6% of the population aged 15-64 years, having used the drug in the last year. An indication of the public health impact of the drug can be seen[...]
Cocaine is Europe's most commonly used illicit stimulant drug, with about 3.6 million adults (aged 15-64) estimated to have used it in the last year. It is the second most seized drug in Europe, after cannabis. Cocaine is trafficked to Europe fr[...]
Comorbidity of substance use and mental health disorders refers to the co-occurrence of a substance use disorder and another mental health disorder in the same individual. In Europe, the presence of psychiatric disorders associated with substanc[...]
FRANÇAIS : Les salles de consommation de drogues à moindre risque dans lesquelles des drogues illicites peuvent être consommées sous la supervision de personnel qualifié, existent en Europe depuis une trentaine d'années. Ces infrastructures ont[...]
Every year, several thousands of cocaine-related emergencies are reported in Europe, along with hundreds of cocaine-related deaths. The types of cocaine-related problems reported are wide-ranging and the relatively high prevalence of cocaine use[...]
Methamphetamine is an established stimulant drug in many parts of the world (e.g. South-east Asia, US), where it has long caused major public health problems. While methamphetamine use in Europe has historically been confined to the Czech Republ[...]
The emergence of new psychoactive substances (NPS) over the last decade has posed a major challenge to drug policy. While the limited available data indicates that prevalence levels of NPS use are relatively low in the general European populatio[...]
Hepatitis C is the most common infectious disease in injecting drug users, among whom it is usually transmitted through the sharing of injecting equipment such as needles and syringes. Most of those who become infected go on to develop chronic H[...]
Over 50 synthetic cathinone derivatives were detected via the EU Early Warning System (EU-EWS) between 2005 and 2013. This 'Perspective on drugs' explores new worrying localised and national outbreaks of injecting these substances and recommends[...]
The Internet is now recognised as a plausible vehicle for delivering drug and alcohol education, prevention and treatment programmes in a range of settings. This 'Perspective on drugs' charts developments in Internet-based drug treatment (IBDT),[...]
Recent years have witnessed a proliferation of new psychoactive substances becoming available in Europe. This can be illustrated through the rise in notifications of new substances to the EU early warning system, from just 14 per year in 2005 to[...]
FRANÇAIS : Trois conventions des Nations unies constituent le cadre juridique international pour le contrôle des drogues illicites. Elles recommandent aux pays de restreindre l'offre de drogues et de limiter leur utilisation à des fins médicale[...]
Europe has long been one of the world's largest consumer markets for cannabis, particularly resin imported mainly from Morocco. In this analysis, we report how Europe's consumer market for cannabis is increasingly dominated by herbal products, w[...]
Historique
